Contraceptives Market Size By Product (Drugs, Devices), By Age Group (Age 15-24, Age 25-34, Age 35-44, Above 44), By Gender (Male, Female), By Distribution Channel (Institutional Sales, Retail Sales, Online Sales), By Geographic Scope And Forecast

Contraceptives Market Size And Forecast

Contraceptives Market size was valued at USD 20.07 Billion in 2023 and is projected to reach USD 31.54 Billion by 2031, growing at a CAGR of 5.81% from 2024 to 2031. Contraceptives, commonly known as birth control methods, are a variety of pharmacological or behavioral interventions used to prevent pregnancy. Contraceptives are primarily designed to inhibit or control the reproductive process, allowing individuals or couples to plan and schedule their pregnancies according to their desires. These interventions can include several forms, including hormonal contraceptives like oral tablets and injectables, intrauterine devices (IUDs), barrier methods like condoms, and fertility awareness practices.

Contraceptives are useful for more than just preventing unwanted pregnancies; they also aid in family planning by allowing individuals to control the timing and spacing of childbirth.

Moreover, contraceptives can be used to treat certain health issues, such as regulating menstrual periods and treating polycystic ovarian syndrome (PCOS).

Contraceptives Market Dynamics

The key market dynamics that are shaping the Contraceptives Market include:

Key Market Drivers

Increasing Awareness of Family Planning:

In recent years, there has been a significant shift in social attitudes regarding reproductive health, with an increased emphasis on making educated family planning decisions. The increase in awareness is being driven by educational campaigns, healthcare initiatives, and the mass diffusion of information via numerous media platforms. As a result, one of the key drivers fueling the contraceptive market is growing awareness of family planning.

Government Initiatives for Birth Control:

Recognizing the societal and economic benefits of controlled population increase, several governments are introducing comprehensive family planning programs. These programs tend to involve activities such as subsidized or free contraception distribution, educational campaigns, and healthcare infrastructure improvement. Thus, government birth control measures are a big driver of the Contraceptives Market.

Growing Acceptance of Contraceptives among Men:

The acceptability of male contraceptives such as condoms and vasectomy demonstrates a good cultural change toward shared family planning. Men who actively participate in contraceptive decisions not only provide couples with more options but also develop a sense of equality in reproductive decision-making. This changing perspective adds to overall market growth by increasing the number of users and broadening the contraceptive methods offered.

Key Challenges:

Side Effects:

Certain contraceptive methods, particularly hormonal ones such as oral contraceptives or injectables, might cause nausea, weight gain, or mood problems. As a result, despite the various benefits of contraception, one key barrier to market growth is anxiety about potential side effects and health consequences connected with their use.

Cultural and Religious Opposition:

Some cultures and religions hold conservative views on reproductive health and family planning, seeing contraception as contradictory to moral or religious precepts. This opposition takes the shape of limited information access, restricted contraceptive availability, or even societal pressure against its usage. Thus, cultural and religious attitudes continue to be important barriers to universal acceptance of contraception in certain countries and populations.

Social Stigma Associated with Contraceptives:

Misconceptions, cultural taboos, and societal judgments all lead to feelings of shame or embarrassment when obtaining or using contraception. This stigma discourages people from freely discussing or using contraceptive choices, which hinders successful family planning.

Key Trends:

Increasing Demand for Long-Acting Reversible Contraceptives (LARCs):

LARCs, which include intrauterine devices (IUDs) and contraceptive implants, provide long-term protection with a single intervention, making them a convenient and effective alternative to daily or regular contraception techniques. LARCs are appealing because of their high efficacy rates, long-term stability, and minimal user-dependent factors, making them ideal for people looking for dependable and low-maintenance birth control options. This trend results rise in demand for LARCs in the contraceptive market.

Rise in Male Contraception Methods:

Male contraceptives, including condoms, vasectomy, and developing hormonal contraceptives, provide a broader choice of possibilities. This trend not only promotes equal participation in reproductive decision-making but also offers couples a wider range of options, personalizing family planning tactics to their specific preferences and needs.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Contraceptives Market Regional Analysis

Here is a more detailed regional analysis of the Contraceptives Market:

North America:

According to Verified Market Research, North America is estimated to dominate the Contraceptives Market during the forecast period. The high level of accessibility and a well-established regulatory framework in the region supports the availability of a diverse range of contraceptive products. This mature market provides customers with a variety of options, demonstrating the region's dedication to reproductive health and family planning.

The prevalence of high awareness and accessibility is another driving force in North America. Moreover, the region's modern healthcare system guarantees widespread access to contraceptive products, making it simple for people from all walks of life to obtain them.

Furthermore, the region is at the forefront of adopting and incorporating modern technology into reproductive health solutions. In North America, innovations like as smartphone fertility tracking apps, smart contraceptive devices, and advances in hormonal contraceptive methods are widely accepted, contributing to a dynamic and progressive market environment.

Europe:

Europe has a well-established Contraceptives Market that is characterized by a balanced mix of conventional and new methods. The region's emphasis on sexual and reproductive health is apparent in readily available healthcare services and popular awareness initiatives. Europe's broad cultural backdrop contributes to a diverse market, supporting a wide range of preferences and family planning options.

The population's growing awareness about sexually transmitted diseases and other health issues is one of the main factors bolstering the application of contraceptives in Europe. Individuals are becoming more aware of the link between reproductive health and general well-being, prompting them to actively seek out and use dependable contraceptives. This health-conscious approach contributes to a consistent demand for a variety of contraception choices, including hormonal and barrier methods.

Furthermore, Europe is witnessing an increasing trend of delayed motherhood, with people choosing to start families later in life. This shift in societal standards contributes to a rise in demand for contraception, as people seek efficient ways to plan and space their pregnancies. The European market responds by providing a variety of solutions for individuals navigating the complications of delayed motherhood.

Asia Pacific:

Asia Pacific emerges as a vibrant and fast-expanding Contraceptives Market, driven by a mix of population growth, increased awareness, and improved healthcare infrastructure. The region's diverse cultural landscape influences the adoption of various contraceptive methods, giving both possibilities and problems for market competitors.

High birth rates in countries like India and China have heightened the focus on family planning, driving up demand for effective contraception. Government initiatives and awareness campaigns actively promote the use of contraception as a responsible way to regulate population increase in this region.

Furthermore, educational campaigns are important in raising awareness about contraception in Asia Pacific. Growing public awareness and acceptance of contraceptives is a result of increased efforts by governments, non-governmental organizations, and healthcare practitioners to educate the public about family planning alternatives in this region.

Contraceptives Market: Segmentation Analysis

The Contraceptives Market is segmented based on Product, Age Group, Gender, Distribution Channel, And Geography.

Contraceptives Market, By Product

• Drugs
• Oral Contraceptive Pills
• Injectable Contraceptives
• Topical Contraceptives
• Devices
• Condoms
• Diaphragms
• Contraceptive Sponges
• Vaginal Rings
• Cervical Cap
• Subdermal Implants
• Intra-uterine Devices

Based on Product, the market is segmented into Drugs and Devices. The hot-melt segment is estimated to dominate the Contraceptives Market. The devices segment dominates the Contraceptives Market. Devices, such as intrauterine devices (IUDs) and contraceptive implants, have gained popularity due to their significant benefits over traditional techniques. These devices provide a long-term and hassle-free alternative to birth control, meeting the modern lifestyle needs for simplicity and dependability. The effectiveness of devices in preventing unplanned pregnancies, combined with their low maintenance requirements, has contributed to their growing popularity among users wanting longer periods of protection without daily involvement. Moreover, advances in device technology, such as the creation of hormonal-releasing IUDs, improve their efficacy and customer satisfaction.

Contraceptives Market, By Age Group

• Age 15-24
• Age 25-34
• Age 35-44
• Above 44

Based on Age Group, the market is segmented into Age 15-24, Age 25-34, Age 35-44, and above 44. The 25-34 age group is estimated to dominate the Contraceptives Market during the forecast period. This age group reflects a life stage marked by higher education, career advancement, and the building of stable partnerships. Individuals in this age group are frequently more active in family planning, looking for dependable contraceptive methods that correspond with their life objectives and aspirations. The desire for control over reproductive choices, along with a greater understanding of the significance of responsible family planning, promotes the demand for contraception among people aged 25 to 34.

Contraceptives Market, By Gender

• Male
• Female

Based on Gender, the market is segmented into Male and Female. The female segment is estimated to dominate the Contraceptives Market during the forecast period. Women have traditionally been the key decision-makers and users of contraceptive techniques, which include a wide range of alternatives from hormonal contraceptives such as oral tablets and injectables to intrauterine devices (IUDs) and barrier methods like condoms. The prevalence of female-centric contraceptive techniques is consistent with biological and societal considerations, as women bear the physical cost of pregnancy and childbirth. Moreover, the evolution of societal norms, in which women are increasingly taking an active role in reproductive health decisions, strengthens their position in the contraceptive industry.

Contraceptives Market, By Distribution Channel

• Institutional Sales
• Hospitals
• Specialty Clinics
• Retail Sales
• Retail Pharmacy
• Drug Stores
• Supermarkets/Hypermarkets
• Online Sales

Based on Distribution Channel, the market is segmented into Institutional Sales, Retail Sales, and Online Sales. The retail sales segment is estimated to dominate the market over the forecast period. Retail sales channels, such as pharmacies, supermarkets, and convenience stores, account for a significant share due to their extensive accessibility and convenience for people looking for contraceptives. These stores offer a discrete and easily accessible setting for people to buy contraception, encouraging a sense of privacy and comfort. In addition, having a varied range of contraceptive options on retail shelves allows consumers to make informed decisions based on their tastes and individual needs. The retail distribution channel not only meets immediate consumer needs, but also serves as an important educational platform, with knowledgeable employees providing advice and information.

Key Players

• The "Contraceptives Market" study report will provide valuable insight emphasizing the global market. The major players in the market are
• Pfizer, Bayer AG, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Novartis AG, Merck & Co. Inc., Shionogi & Co. Ltd., Hisamitsu Pharmaceutical Co. Inc., HIKMA Pharmaceuticals PLC, Lupin Limited, Mankind Pharma Ltd., Glenmark Pharmaceuticals Ltd., Cipla Limited, Abbott Laboratories, Organon & Co., Besins Healthcare Pvt. Ltd., Famy Care Ltd., and DKT International.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In January 2024, Evotec, a medicinal discovery and development business, announced a collaboration with Bayer to create a non-hormonal oral male contraception. This announcement marks a significant advancement in the ongoing hunt for novel and effective male contraceptive methods.
• In January 2024, Teva received FDA approval for Phexxi(R), a non-hormonal vaginal contraception gel. This new method gives women another way to avoid conception without taking hormones.
• In December 2023, Organon announced positive Phase 3 clinical trial findings for AM001, a new long-acting injectable contraception. This new approach could provide women with an easy and efficient form of contraception for up to six months.
• In November 2023, The Bill & Melinda Gates Foundation announced a $8.3 million grant to research a three-month-long-acting contraceptive patch. This new alternative may be especially valuable in areas with limited access to healthcare.